Search This Blog

Wednesday, May 20, 2026

Guardant Health wins FDA approval for next-generation Guardant360 Liquid CDx liquid biopsy

 

Guardant Health wins FDA approval for next-generation Guardant360 Liquid CDx liquid biopsy test

  • FDA-approved Guardant360 Liquid CDx features a 100x expanded genomic footprint for liquid biopsy testing.
  • Guardant360 Liquid CDx incorporates transferred companion diagnostic indications within the new next-generation liquid biopsy assay.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)